2005
DOI: 10.1592/phco.2005.25.11.1536
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Methods for Intravenous Infusion of Fat Emulsion During Extracorporeal Membrane Oxygenation

Abstract: Although both methods were associated with layering out, agglutination, and clot formation, these effects occurred more frequently with administration into the ECMO circuit, particularly in areas of stasis. This may result in disruption of normal ECMO blood flow and impaired delivery of calories. Fat emulsion should therefore be administered through separate intravenous access during ECMO whenever possible.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
18
0
4

Year Published

2010
2010
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 11 publications
0
18
0
4
Order By: Relevance
“…There are suggestions that concomitant infusion of ILE with VA-ECMO could result in fat emulsion agglutination, malfunction of the membrane oxygenator and increased risk of blood clot formation 88. These complications were seen in at least one in vitro study89 and one observational study,90 although two case reports reported no such problems 91 92. An additional seven case reports made no specific comments of any complications 93–99.…”
Section: Discussionmentioning
confidence: 99%
“…There are suggestions that concomitant infusion of ILE with VA-ECMO could result in fat emulsion agglutination, malfunction of the membrane oxygenator and increased risk of blood clot formation 88. These complications were seen in at least one in vitro study89 and one observational study,90 although two case reports reported no such problems 91 92. An additional seven case reports made no specific comments of any complications 93–99.…”
Section: Discussionmentioning
confidence: 99%
“…The infusion of intravenous fat emulsion in patients on ECMO has been reported to cause agglutination in the ECMO circuit, though none was noted in this case. 24 …”
Section: Discussionmentioning
confidence: 99%
“…Concerns remain about appropriate methods of administration of ILE to prevent layering, agglutination, and clotting in areas of flow stasis in the circuit . A very small, prospective study of neonatal ECLS patients was conducted comparing infusion of ILE through the ECLS circuit to infusion via a separate, peripheral IV . The authors describe increased incidences of clotting, as well as layering and agglutination in the ECLS circuit, when ILE is infused into the ECLS circuit directly and suggest that separate IV access be used to administer ILE whenever possible.…”
Section: Nutrition Delivery Routementioning
confidence: 99%
“…21 A very small, prospective study of neonatal ECLS patients was conducted comparing infusion of ILE through the ECLS circuit to infusion via a separate, peripheral IV. 22 The authors describe increased incidences of clotting, as well as layering and agglutination in the ECLS circuit, when ILE is infused into the ECLS circuit directly and suggest that separate IV access be used to administer ILE whenever possible. Further, they suggest that the layering and agglutination noted when ILE is infused through the ECLS circuit may result in impaired delivery of energy, although there were no significant differences in triglyceride levels between groups.…”
Section: Nutrition Delivery Routementioning
confidence: 99%